The Philmus lab’s research centers on bioactive natural products (aka secondary metabolites) from bacteria with a focus on cyanobacteria (photosynthetic bacteria). We develop synthetic biology protocols, bioinformatics programs, and analytical chemistry methodologies to identify, isolate and study these compounds with the potential to serve as drug leads to combat cancer and microbial infections.